Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06656598
Title Study Evaluating the Efficacy and the Tolerance of Immunochemotherapy and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients with Stage III Lung Cancer (SPORADIC)
Acronym SPORADIC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Angers - Centre Paul Papin Angers France Details
Angers - CHU Angers France Details
Avignon - CH Avignon France Details
Boulogne - Ambroise Paré Boulogne France Details
Brest - CHU Brest France Details
Caen - CHU Caen France Details
Caen - CRLCC Caen France Details
Créteil - CHI Créteil France Details
Dijon - CRLCC Dijon France Details
Le Mans - CHG Le Mans France Details
Lille - CRLCC Lille France Details
Marseille - APHM Marseille France Details
Mulhouse - GHRMSA Mulhouse France Details
Paris - Bichat Paris France Details
Paris - Hôpital Cochin Paris France Details
Paris - Tenon Paris France Details
Bordeaux - CHU Pessac France Details
Lyon - HCL Pierre-benite France Details
Rennes - CHU Rennes France Details
Rouen - Centre Henri Becquerel Rouen France Details
Nantes - CRLCC Saint-Herblain France Details
Strasbourg - CRLCC Strasbourg France Details
Toulouse - CHU Toulouse France Details
Tours - CHU Tours France Details
Vandoeuvre-lès-Nancy - CRLCC Vandoeuvre-les-nancy France Details
Metz - Hôpital Robert Schuman Vantoux France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field